Literature DB >> 9145884

Multiple antibiotic resistance in Stenotrophomonas maltophilia.

A Alonso1, J L Martínez.   

Abstract

A cryptic multidrug resistance (MDR) system in Stenotrophomonas maltophilia, the expression of which is selectable by tetracycline, is described. Tetracycline resistance was the consequence of active efflux of the antibiotic, and it was associated with resistance to quinolones and chloramphenicol, but not to aminoglycosides or beta-lactam antibiotics. MDR is linked to the expression of an outer membrane protein (OMP54) both in a model system and in multidrug-resistant clinical isolates.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9145884      PMCID： PMC163865     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

Review 2.  Quinolone antimicrobial agents.

Authors:  H C Neu
Journal:  Annu Rev Med       Date:  1992       Impact factor: 13.739

Review 3.  Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention.

Authors:  E Bergogne-Bérézin; D Decré; M L Joly-Guillou
Journal:  J Antimicrob Chemother       Date:  1993-07       Impact factor: 5.790

4.  A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.

Authors:  S Vartivarian; E Anaissie; G Bodey; H Sprigg; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 5.  Multidrug resistance pumps in bacteria: variations on a theme.

Authors:  K Lewis
Journal:  Trends Biochem Sci       Date:  1994-03       Impact factor: 13.807

Review 6.  Prevention of drug access to bacterial targets: permeability barriers and active efflux.

Authors:  H Nikaido
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Changing etiology of bacteremia in patients with hematological malignancies in Denmark.

Authors:  M Arpi; M A Victor; J K Møller; V Jønsson; M M Hansen; N A Peterslund; B Bruun
Journal:  Scand J Infect Dis       Date:  1994

8.  Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin.

Authors:  M H Wilcox; T G Winstanley; R C Spencer
Journal:  J Antimicrob Chemother       Date:  1994-03       Impact factor: 5.790

9.  Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.

Authors:  S P Cohen; L M McMurry; D C Hooper; J S Wolfson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

10.  Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.

Authors:  M Lecso-Bornet; J Pierre; D Sarkis-Karam; S Lubera; E Bergogne-Berezin
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191
View more
  61 in total

1.  Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

Authors:  M B Avison; C S Higgins; C J von Heldreich; P M Bennett; T R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains.

Authors:  S Valdezate; A Vindel; E Loza; F Baquero; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance.

Authors:  A Alonso; P Sanchez; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

4.  In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; M Fortuna; D Drenaggi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 6.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates.

Authors:  Raquel Barbolla; Mariana Catalano; Betina E Orman; Angela Famiglietti; Carlos Vay; Jorgelina Smayevsky; Daniela Centrón; Silvia A Piñeiro
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

8.  Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF.

Authors:  Patricia Sanchez; Ana Alonso; Jose L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

10.  The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia.

Authors:  María Blanca Sánchez; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.